Appetite-stimulating Hormone Is First Potential Medical Treatment For Frailty In Older Women
Friday, June 12, 2009 - 14:35
in Health & Medicine
Older women suffering from clinical frailty stand to benefit from the first potential medical treatment for the condition, according to a new study. Ghrelin, a hormone that stimulates appetite, was administered to older women diagnosed with frailty, a common geriatric syndrome characterized by unintentional weight loss, weakness, exhaustion and low levels of anabolic hormones which increases risk of falls, hospitalizations, disability and death.
Read the whole article on Science Daily
More from Science Daily
Related
- Appetite-stimulating hormone is first potential medical treatment for frailty in older womenFri, 12 Jun 2009, 11:44:39 EDT
- Risk of frailty in older women dependent on multisystem abnormalitiesThu, 30 Jul 2009, 10:38:14 EDT
- A stronger backbone: DHEA hormone replacement increases bone density in older womenTue, 12 May 2009, 9:52:09 EDT
- Physical frailty may be linked to Alzheimer's diseaseMon, 11 Aug 2008, 17:14:45 EDT
- JNCI news brief: Older cancer patients have more frailty than other seniorsWed, 29 Jul 2009, 17:39:05 EDT